Docking study of quercetin derivatives on inducible Nitric Oxide Synthase and prediction of their absorption and distribution properties

Journal of Applied Sciences

Volumn 10, Issue 23, 2010, Pages 3098-3104

  Kartasasmita, R E ^a   Herowati, R ^a   Gusdinar, T ^a  

^a BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

Author keywords

ADME prediction; Docking; Flavonoids; iNOS; Quercetin derivatives

Indexed keywords

AMIDES; AMINO ACIDS; BINDING ENERGY; BIOCHEMISTRY; CELLS; DOCKING; FORECASTING; HYDROGEN BONDS; LIGANDS; NITRIC OXIDE; PHENOLS; PROTEINS;

DISTRIBUTION PROPERTY; HUMAN INTESTINAL ABSORPTIONS; INDUCIBLE NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE (INOS); INHIBITORY ACTIVITY; INOS; NITRIC OXIDE FORMATION; PLASMA PROTEIN BINDING;

FLAVONOIDS;

EID: 78049413578     PISSN: 18125654     EISSN: 18125662     Source Type: Journal    
DOI: 10.3923/jas.2010.3098.3104     Document Type: Article

References (21)

1. Amir, A., M.A. Siddiqui, N. Kapoor, A. Arya and H. Kumar, 2010. In silico molecular docking of influenza virus (PB2) protein to check the drug efficacy. Trends Bioinform., http://scialert.net/ abstract/?doi=tb.0000.19458.19458
2. ArgusLab 4.0.1, 2004. Planaria software LLC. Seattle.
3. Chen, Y., S. Shen, W. Lee, W. Hou, L. Yang and T.J.F. Lee, 2001. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin and quercetin pentaacetate in RAW 264,7 macrophage. J. Cell. Biochem., 82: 537-548.
4. Coskun, O., M. Kanter, F. Armutcu, K. Cetin, B. Kaybolmaz and O. Yazgan, 2004. Protective effects of quercetin, a flavonoid antioxidant, in absolute ethanol-induced acut gastric ulcer. Eur. J. Gen. Med., 1: 37-42.
5. Francis, S.M., A. Mittal, M. Sharma and P.V. Bharatam, 2008. Design of Benzene-l,2-diamines as selective inducible nitric oxide synthase inhibitors: A combined de novo design and docking analysis. J.Mol. Model, 14: 215-224.
6. Gugler, R., M. Leschik and HJ. Dengler, 1975. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clm. Pharm., 9: 229-234.
7. Hamalainen, M., R. Nieminen, P. Vuorela, M. Heinonen and E. Moilanen, 2007. Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin and daidzein inhibits STAT-1 and NF-EB activation, whereas flavone, isorhamnetin, naringenin and pelargonidin inhihibit only NF-EB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm., 2007: 1-10.
8. Hu, C. and D.D. Kitts, 2004. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS andCOX-2 inRAW264.7 cells. Mol. Cell. Biochem., 265: 107-113.
9. Ji, H.F. and H.Y. Zhang, 2006. Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer's disease. J. Mol. Struct. THEOCHEM., 767: 3-9.
10. Knowles, R.G. and S. Moncada, 1994. Nitric oxide synthasein mammals. Biochem. J., 298: 249-258.
11. Korhonen, R, A. Lahti, H. Kankaanranta and E. Moilanen, 2005. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy, 4: 471-479.
12. Lee, S.K., I.H. Lee, H.J. Kim, G.S. Chang, J.E. Chung and K.T. No, 2003. The PreADME Approach: Web-Based Program for Rapid Prediction of Physico-Chemical, Drug Absorption and Drug-Like Properties. Blackwell Publishing, Massachusetts, pp: 418-420.
13. Morikawa, K., M. Nonaka, M. Narahara, I. Torii and K. Kawaguchi et al., 2003. Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sci., 26: 709-721.
14. Morris, G.M. and M. Lim-Wilby, 2008. Molecular Docking, Methods in Molecular Biology. In: Molecular Modeling of Proteins, Kukol, A. (Ed.). Humana Press, Totowa, New Jersey, pp: 365-382.
15. Oda, A., M. Okayasu, Y. Kamiyama, T. Yoshida, O. Takahashi and H. Matsuzaki, 2007. Evaluation of docking accuracy and investigastions of roles of parameters and each term in scoring functions for protein-ligand docking using arguslab software. Bull. Chem. Soc. Jap., 80: 1920-1925.
16. Oda, A. and O. Takahashi, 2009. Validation of arguslab efficiencies for binding free energy calculations. Chem-Bio. Informatics J., 9: 52-61.
17. Olszanecki, R., A. Gebska, V.I. Kozlovski and R.J. Gryglewski, 2002. Flavonoids and nitric oxide synthase. J. Physiol. Pharmacol., 53: 571-584.
18. Peng, Y., Z. Deng and C. Whang, 2008. Preparation and prodrug studies of quercetin pentabenzensulfonate. YakugakuZasshi, 128: 1845-1849.
19. Rosenfeld, R.J., E.D. Garcin, K. Panda, G. Andersson and A. Aberg et al, 2002. Conformational changes in nitric oxide synthases induced by chlorzoxazone and nitroindazoles: Crystallographic and computational analyses of inhibitor potency. Biochemistry, 41: 13915-13925.
20. Wan, L.L., J. Xia, D. Ye, J. Liu, J. Chen and G. Wang, 2009. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit. Cardiovasc. Ther., 27: 28-33.
21. Zheng, M., Z. Zhang, W. Zhu, H. Liu, X. Luo, K. Chen and H. Jiang, 2006. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): Molecular docking and 3D-QSAR analyses on DHDMBF analogues. Bioorganic Med. Chem., 14: 3428-3437.